1. Karaulov AV, Kalyuzhin OV. Sphere of muramyl dipeptide application within the major approaches to immunotherapy/prophylaxis of infectious diseases. Fiziol. Patol. Immun. Systemy. 2013;17(5):3-15. Russian.
2. Lebedinskaya EA, Lebedinskaya OV, Godovalov AP, Prokudin VS. Immuno-morphological features of the rat’s thymus at the experimental administration of cytostatics. Saratovsk. Nauch.-Med. Zh. 2016;12(1):12-14. Russian.
3. Lebedinskaya EA, Loseva LF, Lebedinskaya OV, Akhmatova NK. Correction of changes in cytokine profile of mice with the induced immunosupression. Tsitokiny Vospalenie. 2011;10(3):108-112. Russian.
4. L’vov VL, Pinegin BV, Khaitov RM, Pashchenkov MV. Patent RU No. 2441906. Composition comprising low-molecular fragments of peptidoglicane of gram-negative bacteria for preventing or treating of human diseases. Bull. No. 4. Published February 10, 2012.
5. Fukuoka M, Takada M, Takifuji N, Sakai N, Ryu S, Masuda N, Matsui K, Negoro S, Kusunoki Y, Tubura E. Restorative effect of muroctasin on leukopenia caused by anticancer chemotherapy in lung cancer. Comparative study by envelope method. Arzneimittelforschung. 1989;39(1):90-93.